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Abstract
Introduction Communicable diseases are the leading
causes of death in Tanzania despite the existence
of effective treatment tools. We aimed to assess the
sociocultural and health system factors associated with
mortality from febrile illness in northern Tanzania.
Methods We interviewed febrile inpatients to determine
prevalence of barriers in seeking or receiving care and
grouped these barriers using the Three Delays model
(delays at home, in transport and at healthcare facilities).
We assessed 6-week mortality and, after matching on age,
gender and severity of illness, measured the association
between delays and mortality using conditional logistic
regression.
Results We enrolled 475 children, of whom 18 (3.8%)
died, and 260 adults, of whom 34 (13.0%) died.
For children, home delays were not associated with
mortality. Among adults, a delay in care-seeking due to
not recognising severe symptoms was associated with
mortality (OR: 3.01; 95% CI 1.24 to 7.32). For transport
delays, taking >1 hour to reach a facility increased odds
of death in children (OR: 3.27; 95% CI 1.11 to 9.66) and
adults (OR: 3.03; 95% CI 1.32 to 6.99). For health system
delays, each additional facility visited was associated with
mortality for children (OR: 1.59; 95% CI 1.06 to 2.38) and
adults (OR: 2.00; 95% CI 1.17 to 3.41), as was spending
>4 days between the first facility visit and reaching tertiary
care (OR: 4.39; 95% CI 1.49 to 12.93).
Conclusion Our findings suggest that delays at home, in
transport and in accessing tertiary care are risk factors
for mortality from febrile illness in northern Tanzania.
Interventions that may reduce mortality include community
education regarding severe symptoms, expanding
transportation infrastructure and streamlining referrals to
tertiary care for the sickest patients.

Introduction
Fever is common in low-resource areas, with a
2-week period prevalence as high as 27%.1 In
Tanzania, common aetiologies among febrile
inpatients include bloodstream infections and
bacterial zoonoses,2 and febrile illnesses are

Key questions
What is already known about this topic?
►► Social autopsy is a retrospective interview tool that

has been used successfully to assess sociocultural
and health systems barriers to care in febrile
illness.
►► Social autopsy is limited, however, by its
retrospective approach and lack of control group.

What are the new findings?
►► Ours is the first study to our knowledge to use the

social autopsy framework in a prospective cohort
study and to determine which sociocultural and
health system factors are associated with mortality.
►► We found that delays in care-seeking, delays in
transport and spending more time between initial
presentation to a health facility and reaching
tertiary level care were all associated with an
increased odds of mortality.

Recommendations for policy
►► Our results suggest that there are social and

health system factors associated with mortality
from febrile illness, which may help explain why
communicable diseases are still the leading causes
of death in Tanzania.
►► Interventions to improve severe illness recognition
in the community, shorten transport times and
expedite referrals to tertiary care when necessary
may help prevent deaths from febrile illness in
northern Tanzania.

still major causes of death3 4 despite the existence of effective treatment tools such as antimicrobials and clinical management guidelines.5 As such, sociocultural, behavioural and
health system factors6–8 may contribute to
mortality from infectious diseases.
Social autopsy has been used to describe
non-biological contributors to fatal infections,
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Home delays
►► Patient reported delay in seeking care due to thinking illness was

not severe but severe symptom was present.
►► Patient waited >24 hours to seek care after onset of severe

symptom.*†

been unable to conclude whether non-biological factors
are truly associated with increased odds of mortality.
Furthermore, few social autopsy studies have enrolled
non-maternal adults. In our study, we adapted social
autopsy for a prospective cohort study of febrile inpatients of all ages. Since our tool is used during life, it is
best described as a ‘social biopsy’. Our objective was to
determine the sociocultural barriers, healthcare-seeking
behaviour and health system factors that are associated
with mortality from febrile illness in northern Tanzania.

►► Patient treated at home despite severe symptom.

Transport delays
►► Patient reported a delay due to transport or cost of transport at any

point.
►► Patient delayed >1 hour to reach a facility at any point.†‡

Health system delay
►► Patient did not get referred to a hospital from the first facility after

onset of severe symptom.
►► Patient did not take themselves to a hospital after onset of severe

symptom (ie, did not ‘short-circuit’ referral).
►► Patient did not receive antibiotics at the first peripheral facility

after onset of severe symptom.
►► Patient reported a barrier at a health facility due to discrimination,

language or physical access.
►► Patient waited >1 hour to receive medication at any point.*
►► Patient visited >2 facilities.† §
►► Patient waited>1 hour to be seen by a provider at any point.*
►► Patient reported delay due to cost of healthcare.
►► Patient did not complete a given treatment due to patient or

caregiver decision.
►► Patient spent >4 days in the healthcare system.†¶
*This threshold was based on a cut-off value used in the social autopsy
literature.
†This delay was also analysed as a continuous variable (see Results).
‡Social autopsy literature has used a cut-off of >2 hours, but our participants’
average transport time was lower and thus a cut-off of 2 hours was not
instructive.
§Social autopsy literature has used a cut-off of >1 facility, but since our study
was hospital based and we were hoping to test whether the WHO Integrated
Management of Childhood Illness and Adult and Adolescent Illness guidelines
of a severe symptom prompting referral to a hospital were being followed, we
set our threshold at >2 facilities.
¶The threshold of >4 days was set post hoc based on our participants’ mean
number days spent in the healthcare system.

including malaria in Tanzania9 and febrile illness and
pneumonia in Uganda.10 11 Administered as a structured
interview to family members following a person’s death,
social autopsy solicits information on healthcare-seeking,
sociocultural barriers to care and barriers within the
healthcare system.12 13 Identification of delays through
social autopsy can provide evidence to inform interventions. For example, a social autopsy study in Niger found
that transport was the main barrier to effective perinatal
care, and the government responded by making motorcycle ambulances available for mothers in labour.14
Standard retrospective social autopsy is limited by
substantial recall15 16 and selection17 bias. In addition,
without non-fatal controls, social autopsy studies have
2

Methods
Study area and population
We enrolled participants at two hospitals in Moshi,
Tanzania, the administrative capital of the Kilimanjaro
Region. Mawenzi Regional Referral Hospital (MRRH)
serves as the region’s tertiary referral hospital with 300
beds. Kilimanjaro Christian Medical Centre (KCMC) is
one of four consultant tertiary hospitals in Tanzania and
has 458 beds, serving a catchment population of more than
10 million people, including people served by MRRH.
Study team members screened all patients admitted to
paediatric and adult medical wards at MRRH and KCMC
from June 2015 to June 2016. Patients were screened as
soon as possible and no later than 48 hours after admission. Patients with a history of fever in the past 72 hours;
tympanic, rectal or oral temperature of ≥38.0°C at admission; or axillary temperature of >37.5°C at admission
were eligible to participate in the study.
Data collection
After obtaining informed consent from the patient or
guardian, trained clinical officers administered a structured interview in Kiswahili. We designed our questionnaire based on the International Network for the Demographic Evaluation of Populations and Their Health
standardised social autopsy tools for child and maternal
death12 and the Child Health Epidemiology Reference
Group social autopsy questionnaire.13 Our questionnaire
captured information on participant demographics, socioeconomic characteristics and barriers to care. We also
asked about the presence of severe symptoms that should
prompt immediate referral to a hospital, as defined by
the World Health Organization Integrated Management
of Childhood Illness (IMCI) and Integrated Management
of Adolescent and Adult Illness (IMAI) guidelines.18 19 We
telephoned participants to assess their vital status within
6 weeks of enrolment in the study.
We defined cases as participants who died within 6 weeks
of enrolment and controls as those who were alive at the
time of follow-up between 3 and 6 weeks after enrolment.
Mirroring the age threshold used at MRRH and KCMC, we
defined paediatric participants as those under 13 years of
age and adults as those 13 years and older. For analysis of
IMCI severe symptoms, we defined infants as participants
younger than 12 months of age and children as paediatric
participants 12 months of age or older.
Snavely ME, et al. BMJ Glob Health 2018;3:e000507. doi:10.1136/bmjgh-2017-000507
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Box 1 List of all 15 barriers to care as used in the severe
febrile illness social biopsy study, Tanzania, 2015–2016,
categorised by home, transport and health system delays
according to the Three Delays model.
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Statistical analysis
We used a matched case–control analysis nested within
our prospective cohort study to measure the association
between barriers to care and mortality for paediatric and
for adult participants, respectively. We assessed 15 barriers
to care, categorised into delays at home, in transport and
within the healthcare system based on the Three Delays
model (box 1).20
Within the paediatric and adult cohorts, respectively, we
matched cases with controls based on age quintile, gender
and severity of illness. We matched on age quintile to allow
for more precise matching on other covariates, and because
in estimating outcome from infection, the broader age
group is likely an appropriate predictor.21–23 When analysing
home and transport delays, we matched only on age and
gender, as the presence of a severe symptom was implicit in
home delays, and transport delays were assessed at multiple
Snavely ME, et al. BMJ Glob Health 2018;3:e000507. doi:10.1136/bmjgh-2017-000507

points in time and thus did not have reference points at
which to measure severity. For healthcare system delays, we
matched on age, gender and severity of illness at the time
of the first encounter with a healthcare facility during the
current illness.
To match on severity of illness, we first determined
separately for infants, children and adults whether cases
and controls had similar distributions of IMCI or IMAI
severe symptoms using the Kolmogorov-Smirnov equality-of-distributions test. If there was a significant difference in distributions, we included a severity of illness
score in the matching algorithm. We generated the
severity of illness score using principal component analysis of the IMCI or IMAI severe symptoms present at time
of study enrolment. Next, we used a logistic regression of
mortality with the principal components as explanatory
variables to predict a severity of illness score at the time
3
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Figure 1 Patients screened, enrolled and reached for follow-up during 1 year of data collection in the severe febrile illness
social biopsy study, Tanzania, 2015-2016.
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Patient involvement
A pilot period ensured patient feedback was incorporated into the questionnaire design. The results of the
study will be made available to patients through dissemination to healthcare providers at MRRH and KCMC.
Research ethics
Informed consent was obtained from all participants. All
authors had full access to relevant study data at all times.
The funding sources had no role in the planning, collection or analysis of data. We attest that we have obtained
appropriate permissions and paid any required fees for
use of copyright protected materials.
Results
Enrolment
From 23 June 2015 to 30 June 2016, we screened 7092
inpatient admissions, of whom 1033 (14.6%) were
enrolled (figure 1). Of those enrolled, 647 (62.6%) were
paediatric and 386 (37.4%) were adult participants. We
administered complete questionnaires and obtained
4

6-week vital status for 735 (71.2%) participants, of whom
475 (64.6%) were paediatric and 260 (35.4%) were adult.
Eighteen (3.8%) paediatric participants and 34 (13.1%)
adults died.
Participant characteristics
Of 475 paediatric participants, the median age was 1.2
(IQR 0.6–2.6) years, 205 (43.2%) were female and 237
(49.9%) participant caregivers had not received education beyond primary school (table 1A). Caregivers of
four (0.8%) participants reported the child being HIV
seropositive.
Of 260 adult participants, the median age was 38.4
(IQR 24.1–52.9) years, 119 (45.8%) were female and 166
(63.8%) had not received education beyond primary
school (table 1B). Sixty-nine (26.5%) adults were farmers
by occupation and 42 (16.2%) reported being HIV
seropositive.
Matched analysis
Both infant and children groups had no differences
between cases and controls in the distributions of severe
symptoms (P=0.960 and P=0.980, respectively). Thus,
matching by severity of illness was not required (online
supplementary table 1). For adults, there was a difference in severe symptom distributions between cases and
controls (P=0.004), and thus adult participants were
matched on age, gender and, for the analysis of health
system delays, severity of illness.
Three delays
Among 475 paediatric participants, 457 (96.2%) experienced at least 1 of 15 total delays, and the median
number of delays per participant was 3 (IQR 2–5). Each
additional delay present during a paediatric illness
was associated with increased odds of death (OR: 1.28;
95% CI 1.03 to 1.59). For adult participants, the median
number of delays per participant was 3 (IQR 2–5), and
248 (95.4%) of 260 participants experienced at least one
delay.
Delays at home
Among paediatric participants, the associations between
delays at home and mortality were not statistically significant (table 2). Among adults, a delay in care-seeking
due to not recognising a severe symptom was associated
with mortality (OR: 3.01; 95% CI 1.24 to 7.32; AF: 23.6%;
95% CI 12.4% to 33.3%). Waiting >24 hours to seek care
after the onset of a severe symptom was also associated
with increased odds of mortality (OR: 2.50; 95% CI 1.11
to 5.63; AF: 34.5%; 95% CI 12.8% to 50.8%). Analysed as
a continuous variable, each additional day between the
onset of a severe symptom and the first attempt to seek
care was associated with mortality (OR: 1.21; 95% CI 1.01
to 1.46). Of the three home delays (box 1), each additional delay present had an OR of 1.73 (95% CI 1.10 to
2.71) for mortality.
Snavely ME, et al. BMJ Glob Health 2018;3:e000507. doi:10.1136/bmjgh-2017-000507
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of first encounter with a healthcare facility during the
current illness.
Our matching algorithm used nearest-neighbour
matching with replacement and subsequent deduplication of controls.24 25 If any cases were left without a
matched control, we reassigned controls such that every
case was matched with at least one control while maintaining maximum closeness of matching. We then consolidated cases and controls across infants and children to
make one paediatric cohort. We measured matching
quality using standardised biases and variance ratios of
covariates between cases and controls.26 27 The ratio of
controls to cases was set at a minimum of two but was
maximised such that the standardised bias remained
below 10.0% for each covariate.28
We measured the association between each delay and
6-week mortality using conditional logistic regression. We
reported results as ORs of mortality with associated population attributable fraction (AF). Statistical analysis was
done using Stata V.14.1. We depicted the differences in the
sequence and type of facilities visited between cases and
controls using an adapted Sankey diagram, generated with
‘The Sankey Diagram Generator’ (Acquire Procurement
Services, Brisbane, Australia).29 30 We designated private
clinics and government-run dispensaries and health centres
as first level facilities. We designated district hospitals as
secondary level care and regional referral and consultant
referral hospitals as tertiary care.31–33
To assess the impact of loss to follow-up, we compared
baseline characteristics between those lost to follow-up and
those included in the analysis using t-tests for means and χ2
tests for proportions. To determine whether a participant’s
clinical presentation was a confounder, we conducted a
sensitivity analysis in which we repeated the conditional
logistic regression of mortality for each delay among the
subset of participants who had each severe symptom.

BMJ Global Health

Characteristic
Age (years)
Duration of illness at time of
enrolment (days)

Survivors
Total (n=475) Cases (n=18) (n=457)

Matched on age and gender*
P value†

Controls (n=142) P value‡

2.2 (2.5)§
6.6 (5.2)§

1.8 (2.2)§
12.4 (13.0)§

2.2 (2.5)§
6.4 (4.5)§

0.524
<0.001

1.9 (2.2)§
6.6 (5.1)§

0.791
<0.001

205 (43.2)

10 (55.6)

195 (42.7)

0.283

75 (52.8)

0.826

 KCMC

251 (52.8)

13 (72.2)

238 (52.1)

 MRRH

224 (47.2)

5 (27.8)

219 (47.9)

232 (48.8)

6 (33.3)

226 (49.5)

57 (40.1)

 Pare

61 (12.8)

5 (27.8)

56 (12.3)

24 (16.9)

 Maasai

16 (3.4)

0 (0.0)

16 (3.5)

5 (3.5)

166 (34.9)

7 (38.9)

159 (34.8)

11 (2.3)

1 (5.6)

10 (2.2)

4 (2.8)

 Primary (1–7 years)

226 (47.8)

10 (55.6)

216 (47.5)

65 (46.1)

 Secondary (8–11 years)

152 (32.1)

6 (33.3)

146 (32.1)

53 (37.6)

2 (0.4)

0 (0.0)

2 (0.4)

0 (0.0)

82 (17.3)

1 (5.6)

81 (17.8)

427 (90.1)

14 (77.8)

413 (90.6)

47 (9.9)

4 (22.2)

43 (9.4)

 Urban

258 (64.7)

6 (46.2)

252 (65.3)

84 (69.4)

 Mixed

22 (5.5)

1 (7.7)

21 (5.4)

5 (4.1)

 Rural

119 (29.8)

6 (46.2)

113 (29.3)

0.363

32 (26.4)

0.236

4 (0.8)

0 (0.0)

4 (0.9)

0.690

142 (100.0)

1.000

174 (36.6)

10 (55.6)

164 (35.9)

0.089

46 (32.4)

0.052

89 (18.7)

1 (5.6)

88 (19.3)

0.144

28 (19.7)

0.142

 Lethargy

87 (18.3)

5 (27.8)

82 (17.9)

0.290

26 (18.3)

0.338

 Inability to drink

48 (10.1)

4 (22.2)

44 (9.6)

0.082

17 (12)

0.225

 Convulsions

79 (16.6)

6 (33.3)

73 (16)

0.052

23 (16.2)

0.075

 Vomiting

244 (51.5)

10 (55.6)

234 (51.3)

0.724

68 (47.9)

0.540

 Stiff neck

12 (2.5)

0 (0)

12 (2.6)

0.486

3 (2.1)

0.534

 Severe skin pustules††

10 (4.9)

0 (0)

10 (5.1)

0.487

4 (6.1)

0.448

Gender
 Female
Admitting hospital
77 (54.2)
0.093

65 (45.8)

0.147

Tribe
 Chagga

 Other

0.180

56 (39.4)

0.601

Education¶
 None

 High school (12–13 years)
 University/college

0.616

19 (13.5)

0.670

Home region
 Kilimanjaro
 Other

130 (91.5)
0.075

12 (8.5)

0.067

Urban status**

Self-reported HIV status
 Positive
Recent hospitalisation (previous
12 months)
 Yes
Has health insurance
 Yes
Severe symptoms on entering
health system

 Less movement††
 Chest indrawing††
 Pus draining from ear††

185 (89.8)

9 (100)

176 (89.3)

0.301

61 (92.4)

0.393

35 (17.2)
1 (0.5)

5 (55.6)
0 (0)

30 (15.4)
1 (0.5)

0.002
0.830

11 (16.7)
1 (1.5)

0.008
0.710
Continued
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Table 1A Background characteristics and prevalence of severe symptoms for 475 paediatric participants in the severe febrile
illness social biopsy study, Tanzania, 2015–2016.
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Characteristic

Survivors
Total (n=475) Cases (n=18) (n=457)

Matched on age and gender*
P value†

Controls (n=142) P value‡

Nasal flaring††

26 (12.7)

1 (11.1)

25 (12.8)

0.885

10 (15.2)

0.748

Bulging fontanelle††
Grunting††

4 (2)
25 (12.2)

0 (0)
1 (11.1)

4 (2)
24 (12.2)

0.665
0.919

1 (1.5)
8 (12.1)

0.710
0.930

Data are reported as n (%) unless otherwise indicated.
*9:1 nearest-neighbour matching with deduplication.
†P value is for the differences between cases and all survivors. P values are derived from t-test for means and χ2 tests for proportions.
‡P value is for the differences between cases and the given set of matched controls. P values are derived from t-test for means and χ2 tests
for proportions.
§Data are reported as mean (SD).
¶
Highest education level completed by the caregiver.
**Urban, mixed or rural were assigned at ward level and are based on classification from the 2012 census that defined urban as, ‘localities
that are identified as urban areas by the district authority’. Mixed refers to wards containing both urban and rural villages.
††Only assessed for participants less than 1 year of age.
KCMC, Kilimanjaro Christian Medical Centre; MRRH, Mawenzi Regional Referral Hospital.

Transport delays
For paediatric participants, taking >1 hour to reach
a healthcare facility at any point was associated with
increased odds of death (OR: 3.27; 95% CI 1.11 to 9.66;
AF: 27.0%; 95% CI 12.9% to 38.8%; table 3). Of the two
transport delays (box 1), each additional delay present
was associated with mortality (OR: 2.45; 95% CI 1.12 to
5.33). Among adults, taking >1 hour to reach a facility
at any point had an OR of 3.03 (95% CI 1.32 to 6.99;
AF: 25.6%; 95% CI 14.3% to 35.5%) for mortality, and
each additional transport delay was associated with 2.16
increased odds of death (95% CI 1.07 to 4.36).
Healthcare system delays
Among paediatric participants, each additional healthcare facility visited was associated with increased
mortality (OR: 1.59; 95% CI 1.06 to 2.38; table 4). Participants spending >4 days between the first presentation
to a healthcare facility and reaching tertiary care had
increased odds of mortality (OR: 4.39; 95% CI 1.49 to
12.93; AF 42.9%; 95% CI 27.4% to 55.1%). Analysed as a
continuous variable, the number of days between the first
presentation to a healthcare facility and reaching tertiary
care was also associated with mortality (OR: 1.09; 95% CI
1.02 to 1.17) per unit time in days.
Among adult participants, visiting >2 healthcare facilities was associated with mortality (OR: 5.33; 95% CI 1.46
to 19.41; AF: 34.5%; 95% CI 18.4% to 47.4%; table 4), as
was spending >4 days between the first presentation to a
healthcare facility and reaching tertiary care (OR: 3.15;
95% CI 1.11 to 8.92; AF: 32.1%; 95% CI 14.7% to 46.0%).
Analysed as a continuous variable, each additional healthcare facility visit was associated with 2.00 increased odds
of death (95% CI 1.17 to 3.41).
Healthcare system pathway
Among paediatric participants, both cases and controls
visited up to four healthcare facilities (figure 2A). Participants not visiting a tertiary level facility within their first
two facility visits had greater odds of death than those
6

who did (OR: 2.88; 95% CI 1.01 to 8.20). Among adult
participants, cases visited up to six healthcare facilities,
whereas no controls visited >3 facilities (figure 2B). Not
reaching tertiary level care within the first two facility
visits was also associated with increased odds of mortality
among adults (OR: 5.24; 95% CI 1.47 to 18.69).
Sensitivity analysis
Among paediatric participants, 103 (59.5%) of those who
were lost to follow-up had a caregiver with no more than
primary school education, compared with 226 (47.8%)
of those in the study cohort (P<0.001; online supplementary table 2A). Of those paediatric participants lost
to follow-up, five (2.9%) participants reported the child
being HIV seropositive compared with four (0.8%) of
those in the study cohort (P=0.049). Forty-four (25.4%)
of the paediatric participants lost to follow-up had one or
more prior hospitalisations in the previous 12 months,
compared with 174 (36.6%) of those in the study cohort
(P=0.008) and 16 (9.2%) of those lost to follow-up
reported having health insurance, compared with 89
(18.7%) of those in the study cohort (P=0.004).
Among adult participants, 8 (6.3%) of those lost to
follow reported having a chronic comorbidity, compared
with 46 (17.7%) of those in the study cohort (P=0.003;
online supplementary table 2B).
In a sensitivity analysis of symptom-specific associations
between delays and mortality, there were no significant
associations between delays and mortality among paediatric or adult participants for any of the severe symptom
subsets (online supplementary table 3A and B).
Discussion
We found that for patients admitted with febrile illness
in northern Tanzania, delays at home, in transport and
in the healthcare system were common. After controlling
for age, gender and severity of illness, death was associated with delayed care-seeking and a lack of recognition
of severe illness by adult participants or their caregivers.
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Table 1A Continued
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Matched on age and
gender*
Characteristic

Survivors
Total (n=260) Cases (n=34) (n=226)

Age (years)

40.3 (17.9)¶

47.6 (20.4)¶

39.2 (17.2)¶

0.011

44.5 (18.2)¶

0.402

43.1 (18.6)¶

0.306

9.6 (10.4)¶

15.1 (16.0)¶

8.8 (9.0)¶

0.001

8.2 (7.8)¶

0.001

9.7 (12.9)¶

0.103

118 (45.9)

13 (38.2)

105 (47.1)

0.335

51 (41.8)

0.708

14 (29.8)

0.426

 KCMC

112 (43.1)

22 (64.7)

90 (39.8)

 MRRH

148 (56.9)

12 (35.3)

136 (60.2)

136 (52.3)

17 (50)

119 (52.7)

71 (58.2)

23 (48.9)

34 (15.0)

15 (12.3)

7 (14.9)

Duration of illness at
time of enrolment (days)

Controls
P value‡ (n=122)

Matched on age,
gender and severity of
illness†

Controls
P value§ (n=47)

P value§

Gender
 Female
Admitting hospital
51 (41.8)
0.006

71 (58.2)

22 (46.8)
0.018

25 (53.2)

0.111

Tribe
 Chagga
 Pare
 Maasai

41 (15.8)

7 (20.6)

4 (1.5)

0 (0.0)

4 (1.8)

79 (30.4)

10 (29.4)

69 (30.5)

7 (2.7)

1 (2.9)

6 (2.7)

3 (2.5)

1 (2.1)

159 (61.2)

23 (67.6)

136 (60.2)

82 (67.2)

29 (61.7)

57 (21.9)

9 (26.5)

48 (21.2)

18 (14.8)

9 (19.1)

 High school (12–
13 years)

6 (2.3)

0 (0.0)

6 (2.7)

4 (3.3)

3 (6.4)

 University/college

31 (11.9)

1 (2.9)

30 (13.3)

217 (83.5)

25 (73.5)

192 (85.0)

43 (16.5)

9 (26.5)

34 (15.0)

 Urban

104 (54.7)

6 (35.3)

98 (56.6)

55 (56.7)

21 (60.0)

 Mixed

6 (3.2)

1 (5.9)

5 (2.9)

1 (1.0)

0 (0.0)

 Rural

80 (42.1)

10 (58.8)

70 (40.5)

0.227

41 (42.3)

0.131

14 (40.0)

0.118

42 (16.2)

6 (17.6)

36 (15.9)

0.800

20 (16.4)

0.862

7 (14.9)

0.739

72 (27.7)

9 (26.5)

63 (27.9)

0.864

35 (28.7)

0.799

13 (27.7)

0.905

61 (23.6)

6 (17.6)

55 (24.4)

0.384

31 (25.6)

0.335

13 (27.7)

0.294

160 (62.3)

23 (67.6)

137 (61.4)

0.486

88 (72.7)

0.562

30 (65.2)

0.820

 Farmer

69 (26.5)

12 (35.3)

57 (25.2)

35 (28.7)

16 (34.0)

 Student

37 (14.2)

5 (14.7)

32 (14.2)

16 (13.1)

8 (17.0)

 Merchant

43 (16.5)

2 (5.9)

41 (18.1)

 Labourer

37 (14.2)

6 (17.6)

31 (13.7)

 Other

2 (1.6)
0.746

34 (27.9)

1 (2.1)
0.533

16 (34)

0.746

Education**
 None
 Primary (1–7 years)
 Secondary (8–
11 years)

0.380

15 (12.3)

0.238

5 (10.6)

0.356

Home region
 Kilimanjaro
 Other

110 (90.2)
0.095

12 (9.8)

40 (85.1)
0.012

7 (14.9)

0.197

Urban status††

Self-reported HIV status
 Positive
Recent hospitalisation
(previous 12 months)
 Yes
Has health insurance
 Yes
Marital status
 Married
Occupation

21 (17.2)
0.521

15 (12.3)

4 (8.5)
0.644

4 (8.5)

0.833

Continued
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Table 1B Background characteristics and prevalence of severe symptoms for 260 adult participants in the severe febrile
illness social biopsy study, Tanzania, 2015–2016.

BMJ Global Health
Continued
Matched on age and
gender*
Characteristic

Survivors
Total (n=260) Cases (n=34) (n=226)

Controls
P value‡ (n=122)

Matched on age,
gender and severity of
illness†

Controls
P value§ (n=47)

P value§

Has chronic
comorbidity
46 (17.7)

7 (20.6)

39 (17.3)

0.635

Weakness

55 (21.2)

18 (52.9)

37 (16.4)

<0.001

Difficulty breathing

43 (16.5)

9 (26.5)

Confusion

11 (4.2)

5 (14.7)

6 (2.7)

0.001

Lethargy

23 (8.8)

11 (32.4)

12 (5.3)

<0.001

Inability to drink

13 (5)

5 (14.7)

8 (3.5)

0.005

3 (2.5)

 Yes

26 (21.3)

0.927

7 (14.9)

0.504

<0.001

19 (40.4)

0.264

0.026

12 (25.5)

0.924

3 (2.5)

0.316

3 (6.4)

0.215

4 (3.3)

<0.001

7 (14.9)

0.062

0.316

4 (8.5)

0.381

Severe symptoms
present on entering the
health system
34 (15)

0.095

11 (9)
7 (5.7)

Convulsions

2 (0.8)

0 (0)

2 (0.9)

0.582

2 (1.6)

0.452

1 (2.1)

0.392

Stiff neck

9 (3.5)

2 (5.9)

7 (3.1)

0.408

1 (0.8)

0.057

2 (4.3)

0.739

64 (24.6)

8 (23.5)

56 (24.8)

0.875

19 (15.6)

0.771

7 (14.9)

0.323

Abdominal pain

Data are reported as n (%) unless otherwise indicated.
*6:1 nearest-neighbour matching with deduplication.
†2:1 nearest-neighbour matching with deduplication.
‡P value is for the differences between cases and all survivors. P values are derived from t-test for means and χ2 tests for
proportions.
§P value is for the differences between cases and the given set of matched controls. P values are derived from t-test for means and
χ2 tests for proportions.
¶
Data are reported as mean (SD).
**Highest education level completed by the patient.
††Urban, mixed or rural were assigned at ward level and are based on classification from the 2012 census that defined urban as,
‘localities that are identified as urban areas by the district authority’. Mixed refers to wards containing both urban and rural villages.
KCMC, Kilimanjaro Christian Medical Centre; MRRH, Mawenzi Regional Referral Hospital.

Mortality was also higher among paediatric and adult
participants who experienced delays in transport and
delays in reaching tertiary level care. Presenting to
multiple lower-level healthcare facilities was associated
with increased odds of death and may be one reason for
delayed presentations to tertiary-level care. The findings
in this ‘social biopsy’ study suggest that community education regarding severe symptom recognition, improved
transport infrastructure and ensuring rapid referrals
to tertiary level facilities may help prevent deaths from
febrile illnesses.
Delays at home were associated with increased odds
of mortality among adult but not paediatric participants. The distinction between the effects of paediatric
and adult delays is important for two reasons. First,
social autopsy studies have reported the importance of
delays at home among fatal paediatric illness. A study in
Uganda found that 42% of 174 fatal childhood illnesses
had delayed seeking care for >24 hours after the onset
of a severe symptom.12 In Ghana, it was shown that 50%
of 264 severe childhood illness were not recognised as
severe.34 However, we have demonstrated that delays at
home were common in both fatal and non-fatal paediatric febrile illnesses, yet they did not increase the odds
8

of death and thus may not be the most important targets
for intervention. Second, social autopsy studies have not
focused on non-maternal adults. We found that delayed
care-seeking due to a lack of severe illness recognition is
associated with mortality among adults. This association
suggests that >30% of febrile deaths among working-age
adults might be prevented through education about the
severe symptoms that should prompt care-seeking.
We found that a delay >1 hour in reaching a facility
at any point during an illness increased the odds of
mortality among paediatric and adult participants.
Several social autopsy studies have found transport delays
to be common.12 14 35–37 However, these studies only
considered transport delays to the first or last facility.
When we limited our analysis to the first or last facility,
the association between >1 hour delay and mortality was
not significant. We also found that each additional transport delay was associated with increased odds of death.
Thus, the association of transport delays with mortality
was additive and delays in transport to facilities between
the first and last were associated with mortality. An initial
intervention may be to strengthen referral transportation infrastructure, which could be followed by community ambulance services, which currently are unavailable
Snavely ME, et al. BMJ Glob Health 2018;3:e000507. doi:10.1136/bmjgh-2017-000507
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Table 1B

0.9 (0.8)¶

Total number of dichotomous home delays present

1.17 (0.64 to 2.15)

0.91 (0.70 to 1.19)

0.97 (0.34 to 2.71)

0.87 (0.26 to 2.93)

1.15 (0.29 to 4.56)

0.615

0.508

0.948

0.828

0.846

P value

–

–

–

–

–

1.2 (1.0)¶

3.3 (5.9)¶

6 (17.6)

20 (58.8)

12 (35.3)

0.7 (0.8)¶

1.3 (1.6)¶

28 (23.0)

31 (33.0)

20 (16.4)

Controls
(n=122)‡

1.73 (1.10 to 2.71)

1.21 (1.01 to 1.46)

0.66 (0.25 to 1.73)

2.50 (1.11 to 5.63)

3.01 (1.24 to 7.32)

OR (95% CI)

–

–

–

34.5 (12.8 to 50.8)

23.6 (12.4 to 33.3)

AF§ (95% CI)

0.8 (1.2)**

1.3 (2.4)**
0.6 (0.7)**

Transport time to last facility (hours)

Total number of dichotomous transport delays
present

2.45 (1.12 to 5.33)

1.23 (0.94 to 1.60)

1.28 (0.89 to 1.85)

3.27 (1.11 to 9.66)

2.67 (0.66 to 10.76)

0.024

0.126

0.180

0.032

0.167

P value

–

–

–

27.0 (12.9 to 38.8)

–

AF§ (95% CI)

0.4 (0.6)**

0.8 (1.2)**

0.7 (0.9)

13 (38.2)

2 (5.9)

0.2 (0.5)**

0.8 (1.6)**

0.5 (1.0)

20 (16.4)

7 (5.7)

Controls
(n=122)‡

2.16 (1.07 to 4.36)

1.06 (0.84 to 1.34)

1.20 (0.86 to 1.67)

3.03 (1.32 to 6.99)

1.01 (0.18 to 5.52)

OR (95% CI)

*Paediatric analysis is based on 9:1 nearest-neighbour matching with deduplication based on age and gender.
†Adult analysis is based on 6:1 nearest-neighbour matching with deduplication based on age and gender.
‡Data are reported as n (%) unless otherwise noted.
§Attributable fraction is reported as a percentage and is only given for the dichotomous delays significantly associated with mortality on conditional logistic regression analysis.
¶We also estimated the OR for this delay at the first facility, the last facility and the first or last facility, none of which were significant.
**Data reported as mean (SD).
AF, attributable fraction.

0.2 (0.5)**

0.5 (0.8)**

26 (18.4)

9 (6.3)

0.9 (2.0)**

7 (38.9)

Patient delayed >1 hour to reach a facility at any
point¶

Transport time to first facility (hours)

3 (16.7)

OR (95% CI)

Cases
(n=34)‡

Patient reported a delay due to transport or cost of
transport at any point

Transport delay

Adult (n=156)†

Cases
(n=18)‡

Controls
(n=142)‡

Paediatric (n=160)*

0.031

0.600

0.286

0.009

0.995

P value

–

–

–

25.6 (14.3 to 35.5)

–

AF§ (95% CI)

OR for 6-week mortality by transport delays among paediatric and adult participants in the severe febrile illness social biopsy study, Tanzania, 2015–2016

0.017

0.039

0.396

0.027

0.015

P value
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Table 3

*Paediatric analysis is based on 9:1 nearest-neighbour matching with deduplication based on age and gender.
†Adult analysis is based on 6:1 nearest-neighbour matching with deduplication based on age and gender.
‡Data are reported as n (%) unless otherwise noted.
§Attributable fraction is reported as a percentage and is only given for the dichotomous delays significantly associated with mortality on conditional logistic regression analysis.
¶Data reported as mean (SD).
AF, attributable fraction.

1.0 (0.8)¶

55 (39.0)
1.6 (3.0)¶

Patient treated at home despite severe symptom

37 (32.5)

7 (38.9)

5 (31.2)

Patient waited >24 hours to seek care after onset of severe
symptom

20 (14.1)

Time taken to seek care after onset of severe symptom (days) 1.2 (1.6)¶

3 (16.7)

Patient reported delay in seeking care due to thinking illness
was not severe but severe symptom was present

OR (95% CI)

Adult (n=156)†
Cases
(n=34)‡

AF§
(95% CI)

Cases
(n=18)‡

Controls
(n=142)‡

Paediatric (n=160)*

OR for 6-week mortality by home delays among paediatric and adult participants in the severe febrile illness social biopsy study, Tanzania, 2015–2016

Home delay

Table 2
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2.5 (1.4)†
8.8 (12.0)† 3.4 (4.5)†
3.7 (1.7)†
5.2 (2.4)†

Total number of dichotomous health system delays
present

Total number of dichotomous home, transport and
health system delays present

1.28 (1.03 to 1.59)

1.27 (0.99 to 1.64)

1.09 (1.02 to 1.17)

1.59 (1.06 to 2.38)

4.39 (1.49 to 12.93)

1.05 (0.38 to 2.90)

2.26 (0.62 to 8.30)

0.75 (0.26 to 2.17)

2.57 (0.92 to 7.22)

1.02 (0.36 to 2.89)

2.63 (0.92 to 7.54)

0.62 (0.08 to 4.94)

1.64 (0.60 to 4.44)

0.85 (0.29 to 2.47)

0.027

0.064

0.009

0.024

0.007

0.926

0.218

0.600

0.073

0.966

0.073

0.648

0.335

0.770

–

–

–

–

42.9 (27.4 to
55.1)

–

–

–

–

–

–

–

–

–

AF§ (95% CI)

1.9 (0.9)†

10 (21.3)

12 (25.5)

4 (8.5)

13 (27.7)

10 (21.3)

15 (31.9)

11 (23.4)

4 (8.7)

11 (28.2)

31 (67.4)

4.9 (2.7)†

3.3 (2.2)†

3.9 (2.6)†

2.6 (2.0)†

10.0 (14.9)† 4.5 (7.5)†

2.8 (1.7)†

16 (47.1)

13 (38.2)

3 (8.8)

8 (23.5)

16 (47.1)

9 (26.5)

6 (17.6)

6 (17.6)

11 (32.4)

24 (70.6)

1.16 (0.96 to 1.40)

1.02 (0.94 to 1.53)

1.06 (1.00 to 1.13)

2.00 (1.17 to 3.41)

3.15 (1.11 to 8.92)

2.20 (0.73 to 6.64)

0.91 (0.20 to 4.12)

0.66 (0.22 to 2.02)

3.73 (1.19 to 11.69)

0.76 (0.29 to 2.00)

0.80 (0.26 to 2.51)

2.15 (0.59 to 7.75)

1.07 (0.30 to 3.78)

1.13 (0.43 to 2.92)

OR (95% CI)

0.133

0.153

0.054

0.011

0.030

0.163

0.898

0.468

0.024

0.573

0.703

0.243

0.915

0.808

P value

–

–

–

–

32.1 (14.7 to 46.0)

–

–

–

34.5 (18.4 to 47.4)

–

–

–

–

–

AF§ (95% CI)

*Paediatric analysis is based on 9:1 nearest-neighbour matching with deduplication based on age and gender.
†Adult analysis is based on 2:1 nearest-neighbour matching with deduplication based on age, gender and severity of illness.
‡Data are reported as n (%) unless otherwise noted.
§Attributable fraction is reported as a percentage and is only given for the dichotomous delays significantly associated with mortality on conditional logistic regression analysis.
¶This was a composite delay created due to anticipated low prevalence of three separate delays. A participant had this composite delay if the patient experienced at least one of the following during at least one facility
encounter: discrimination, a language barrier or a physical access barrier.
**We also estimated the OR for this delay at the first facility, the last facility and the first or last facility, none of which were significant.
††Data reported as mean (SD).
AF, attributable fraction.

3.9 (2.2)†

2.8 (1.7)†

1.9 (0.9)†

32 (22.5)

46 (32.4)

Time spent in the health care system (days)

11 (7.7)

47 (33.3)

26 (18.3)

Total number of facilities visited

5 (27.8)

Patient waited >1 hour to be seen by a provider at any
point**

10 (55.6)

7 (38.9)

Patient visited >2 facilities

43 (30.7)

Patient spent >4 days in the health care system

6 (33.3)

Patient waited >1 hour to receive medication at any
point**

27 (19.0)

6 (33.3)

7 (38.9)

Patient reported a barrier at a health facility due to
discrimination, language or physical access¶

13 (9.3)

3 (16.7)

1 (5.6)

Patient did not receive antibiotics at the first peripheral
facility after onset of severe symptom

43 (36.1)

Patient did not complete a given treatment due to
patient or caregiver decision

8 (47.1)

Patient did not take themselves to a hospital after onset
of severe symptom (i.e. did not ‘short-circuit’ referral)

94 (68.6)

Patient reported delay due to cost of health care

12 (66.7)

Patient did not get referred to a hospital from the first
facility after onset of severe symptom

P value

Controls
(n=47)‡

OR (95% CI)

Cases
(n=34)‡

Adult (n=81)†

Controls
(n=142)‡

Paediatric (n=160)*
Cases
(n=18)‡

OR for 6-week mortality by health system delays among paediatric and adult participants in the severe febrile illness social biopsy study, Tanzania, 2015–2016
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in northern Tanzania and have been associated with
decreased mortality in other settings.38–40
By enrolling at the tertiary hospital level, our study
was well suited to examine health system delays, which
previous studies have often neglected in favour of
analysing patient decision-making delays.41 We found
that spending >4 days between the first facility presentation and reaching tertiary care had an increased odds
of mortality for both adult and paediatric participants.
In fact, 42.9% of paediatric and 32.1% of adult febrile
deaths may be attributable to taking >4 days to reach
tertiary care. Furthermore, each additional facility visit
increased the odds of death. A social autopsy study on
fatal childhood pneumonia in Uganda showed that only
22% of patients initially taken to a clinic were referred
to a district hospital and that only 31% of those who
reached a district hospital were referred to tertiary
care.11 We identified similar delays in reaching referral or
higher level care and demonstrated that such delays were
associated with increased odds of mortality. Therefore,
referring the sickest febrile patients directly to tertiary
care may reduce the risk of death associated with febrile
illness in Tanzania.
One limitation of our design was selection bias due
to hospital-based enrolment. Patterns of delays among
non-hospitalised febrile patients may differ from the
patterns we identified in our study, and for this reason,
our future work will include healthcare utilisation data
from community members. There may have been additional selection bias from limiting our analysis to those
participants who could be reached for follow-up. To
Snavely ME, et al. BMJ Glob Health 2018;3:e000507. doi:10.1136/bmjgh-2017-000507

assess this bias, we compared background characteristics
between those lost to follow-up and those in the study
cohort. The study cohort was more likely to report having
health insurance, higher levels of education and at least
one hospitalisation in the past 12 months. However, as
one might expect delays to be more impactful among
families with lower socioeconomic status, we speculate
that our lost to follow-up bias would likely underestimate
of the impact of delays, though we cannot conclusively
infer the direction of bias. Also, while we used a robust
matching process, this process introduced recall bias
through participants’ listing of severe symptoms. Our
matching process also did not control for HIV seropositivity, as HIV status was self-reported and not laboratory
confirmed. However, the prevalence of self-reported HIV
seropositivity was balanced between cases and controls.
Our findings point to directions for future research
and potential interventions. Future research may include
characterising the determinants of the Three Delays
that are associated with mortality, such as describing
the explanatory models for illness among our patient
population or studying the main areas of socioeconomic
inequity in the community. Our results suggest interventions in our catchment area could include programmes
to improve illness recognition in the community such
as training community health workers42 43 or teachers44
to recognise severe illness. Improved interfacility or
community ambulances may help counter delays in transport. Our findings suggest at least two points of intervention to minimise health system delays. The first would
be ensuring that all Tanzanian healthcare personnel
11

BMJ Glob Health: first published as 10.1136/bmjgh-2017-000507 on 21 February 2018. Downloaded from http://gh.bmj.com/ on May 12, 2020 by guest. Protected by copyright.

Figure 2 Pathway analysis comparing the pathways through the healthcare system between paediatric and adult cases and
matched controls in the severe febrile illness social biopsy study, Tanzania, 2015–2016. Note: from left to right, the diagram
depicts each subsequent healthcare facility encounter, such that participants who visited a higher number of facilities have
pathways that extend further to the right. The numbers on each node represent the number of participants presenting to that
facility and the proportion of total patients traveling to each facility type is reflected in the width of bars flowing from one facility
to the next. An individual’s pathway ends when he or she reaches MRRH or KCMC represented by the red segments. Matching
on severity of illness was done at the time of visiting the first facility, such that cases and controls are equally sick in column
1 of the diagram. MRRH and KCMC were combined in the pathway diagram, as they both provide tertiary-level referral care
and they represent the end of participants’ healthcare system pathways at the time of enrolment. MRRH, Mawenzi Regional
Referral Hospital; KCMC, Kilimanjaro Christian Medical Centre.
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